Neurology & Psychiatry | Allucent
Home  /  Therapeutic Expertise  /  Neurology & Psychiatry
Neurology & Psychiatry

Maximize Your Clinical Research Potential with the Leading Neuroscience CRO

SCROLL

Comprehensive Neuroscience Trials by a Trusted CNS CRO

Neurological clinical trials face a range of unique challenges due to the complexity of the peripheral and central nervous systems, the intricate nature of neurological diseases, and the difficulty in measuring neurological and psychiatric outcomes. Cognitive impairments, behavioral abnormalities, reduced motor capability, and sensory deficiencies all create a high burden on both patients and caregivers.

As a leading neuroscience CRO, Allucent has supported neuroscience trials for more than 30 years. With over 140 clinical trials in more than 40 indications, we continue to bring hope and breakthrough treatments to countless patients suffering from neurological disorders.

Dedicated Experts Committed to Advancing Neuroscience Clinical Research

Neurological clinical development requires the specialized services and solutions of a neuroscience CRO to ensure a comprehensive regulatory strategy, a robust study design, effective patient-focused recruitment strategies, and industry-leading technology solutions for successful neuroscience trials.
 
Allucent Center of Expertise: Neuroscience, offers cross-functional expertise through clinical pharmacology experts, regulatory strategists, biostatistical consultants, medical affairs, and operational experts, who share your deep commitment to developing therapies for neurodegenerative, neurological, rare neurological, pain, and psychiatric conditions to enhance your neuroscience clinical research.

Click icons for more information:

Marcus Delatte - VP, Regulatory Strategy

Our team has developed deep and wide expertise in neuroscience clinical research via our experiences conducting and advancing clinical trials for various indications that include the treatment of addiction disorders, pain disorders, Alzheimer’s disease, Huntington’s disease, psychosis, and seizure disorders. This expertise has allowed Allucent to gain the trust of our partners developing products for rare and other types of diseases, as well as to best position them for success when engaging global regulatory authorities at various stages of the drug development life cycle.

Marcus Delatte

VP, Regulatory Strategy

Depth of Neurology & Psychiatry Clinical Trial Experience

As a neuroscience CRO, Allucent has conducted a wide range of neuroscience trials, from early phase trials where dose escalation was dependent on repeated CSF sampling and neuroimaging, to worldwide Phase III trials with various interim analyses or adaptive designs.

140+

Studies

1,990+

Sites

15,500+

Patients

720+

Consulting Projects

All-time years of experience

With a global breadth and depth across a wide range of neurology & psychiatry indications, Allucent is a trusted neuroscience CRO partnering with biotech companies to bring innovative therapies to light.

Meet Some of Our Neuroscience & Psychiatric Drug Experts

Lisa Benincosa, PhD

SVP,
Clinical Pharmacology Strategy

Lisa Benincosa, PhD - LinkedIn Page

Marcus Delatte, PhD

VP,
Regulatory Strategy

Marcus Delatte, PhD - LinkedIn Page

Gilad Rosenberg, MD, MSc

Executive Medical Director, Therapeutic Medical Area Lead, Neuroscience

Gilad Rosenberg, MD, MSc - LinkedIn Page

Maria Jesus Seivane

Global Operations Head,
Neuroscience

Maria Jesus Seivane - LinkedIn Page

Related Content

Additional Resources

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

Subscribe to our monthly newsletter